Breaking News
0

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Gilead's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
63.99 +0.73    +1.15%
11/10 - Closed. Currency in USD ( Disclaimer )
After Hours
64.01
+0.02
+0.03%
19:12:17 - Real-time Data
Type: Equity
Market: United States
ISIN: US3755581036 
CUSIP: 375558103
  • Volume: 5,650,620
  • Bid/Ask: 64.00 / 64.43
  • Day's Range: 63.67 - 64.49
Gilead 63.99 +0.73 +1.15%

GILD Overview

 
This is the main Gilead Sciences Inc stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close63.26
Day's Range63.67 - 64.49
Revenue22.36B
Open63.95
52 wk Range60.32 - 76.44
EPS4.63
Volume5,650,620
Market Cap81.04B
Dividend (Yield)2.52 (3.98%)
Average Vol. (3m)5,976,063
P/E Ratio13.82
Beta1.1
1-Year Change - 13.05%
Shares Outstanding1,266,455,481
Next Earnings DateOct 24, 2019
What is your sentiment on Gilead?
or
Market is currently closed. Voting is open during market hours.

Gilead Sciences Inc News


Gilead Sciences Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Buy Buy Neutral Strong Sell
Technical Indicators Sell BUY Strong Buy Strong Buy Strong Sell
Summary Sell Buy Strong Buy Buy Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Doji Star Bearish 1D Current
Bullish Engulfing 1W Current
Bullish Hammer 1M Current
Dragonfly Doji 1M Current
Completed Patterns
Dragonfly Doji 1H 2 Oct 11, 2019 01:00PM
Three Inside Up 1W 6 Sep 01, 2019
Engulfing Bearish 1M 12 Oct 18

Gilead Sciences Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 63.99 64.00 64.43 5,650,620 +1.15% USD 11/10  
  Mexico 1,228.61 0.00 0.00 0 +0.00% MXN 10/10  
  Switzerland 66.000 60.000 100.000 0 +0.00% CHF 13/06  
  Switzerland 67.230 0.000 0.000 0 +0.00% USD 04/04  
  Frankfurt 58.04 57.77 57.95 169 +0.29% EUR 02:01:00  
  Berlin 58.010 57.730 58.020 0 +0.61% EUR 02:08:00  
  TradeGate 58.01 57.80 58.01 244 -0.50% EUR 04:10:00  
  Munich 58.000 57.720 58.010 0 -0.12% EUR 03:27:00  
  Xetra 57.9700 57.8300 57.9800 144 -0.55% EUR 03:04:00  
  Stuttgart 57.990 59.570 59.720 0 0.00% EUR 11/10  
  Vienna 58.230 64.960 66.780 0 0.00% EUR 11/10  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 236.21 237.64 232.31 +6.12 +2.66% 41.99M 11/10  
  Facebook 184.19 186.49 182.14 +4.16 +2.31% 15.00M 11/10  
  Alphabet A 1,215.71 1,228.75 1,213.64 +6.24 +0.52% 1.13M 11/10  
  Tesla 247.89 251.08 246.81 +3.15 +1.29% 8.49M 11/10  
  Amazon.com 1,731.92 1,745.45 1,729.86 +11.66 +0.68% 3.28M 11/10  
  Yandex 29.99 32.63 28.91 -5.57 -15.66% 34.46M 11/10  
  IBM 142.76 144.50 142.61 +1.63 +1.16% 3.02M 11/10  
  Netflix 282.93 287.87 275.89 +2.45 +0.87% 8.82M 11/10  
  Ferrari NV 153.32 154.62 151.99 +3.17 +2.11% 410.99K 11/10  
  Microsoft 139.68 141.03 139.50 +0.58 +0.42% 25.55M 11/10  

Gilead Sciences Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

11000

Equity Type

ORD

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
Securities Investor Protection Corporation (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Pedro Curado
Pedro Curado Aug 23, 2019 5:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy end get ready for long fall
Chris Martin
Chris Martin Aug 23, 2019 1:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You say this based on what... ? Parroting a few others? Fou didn't mean thin how short you are smart guy -
Noala Kungdda
Noala Kungdda Aug 20, 2019 9:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It is really lovely stock....Good future with almost 4% of divideneded.
Patunja Patato
Patunja Patato Jul 14, 2019 6:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now it is, time to buy
Shaq Attaq
Shaq Attaq Apr 25, 2019 6:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good time to buy
Dale Frisky
Dale Frisky Mar 31, 2019 5:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The company is poised for a major breakout upwards.
Padraig Crowley
Padraig Crowley Jul 06, 2018 4:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
am short GILD from $67 - anyone else think that the price will go lower than that at some stage over the summer?
태범 김
태범 김 Jul 06, 2018 4:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No. The company is poised for a major breakout upwards. It has positioned itself a leader in cell therapy with Kite Pharma acquisition, and has a strong base in the HIV market which is a huge cash cow, and still maintains considerable presence in Hepatitis B, C markets. . . While Hepatitis C market is bound to shrink, the company's anti-viral platform is not something that's to be looked over. . . Also coming out are NASH treatment regiments which if approved will be HUGE. . . There are some ifs to a bull case, but we all know that we have to place our bets in the defining moments.
yusuf zubir
yusuf zubir Jan 27, 2018 8:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any comment on earning? Momentum?
Sal Monella
Sal Monella Nov 16, 2017 6:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Typical WALL STREET fraud & theft! Company beats earnings estimates for 4 consecutive quarters TOP to BOTTOM & they crash the stock by 15% in following 3-4 weeks, after KITE acquisition & positive FDA Nescarta data. Even that greedy ***of a fraudster Jim Cramer was still telling people to sell in the low 70s. Please God. Next time, put Cramer in that bike path for the next lone wolf to run over.
Episcopolian OptionTrader
Episcopolian1 Oct 02, 2017 1:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$GILD The NASH Phase 2 data release iis now delayed until end-of-the-yea, possibly 1st qtr of 2018. Not good! but very good sign for $ICPT
Episcopolian OptionTrader
Episcopolian1 Oct 02, 2017 1:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sell $GILD and buy $ICPT
Episcopolian OptionTrader
Episcopolian1 Sep 28, 2017 10:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Floor chatter about Phase 2 NASH has failed!
Episcopolian OptionTrader
Episcopolian1 Sep 28, 2017 10:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A bad feeling about $GILD's COO retirement announcement, right before NASH announcement!!!
Episcopolian OptionTrader
Episcopolian1 Mar 17, 2017 9:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Price target raised to $110
Episcopolian OptionTrader
Episcopolian1 Mar 10, 2017 9:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GILD is about to announce a huge acquisition. Buy it before that happens. $100 price target!.
Danny Alasha
Danny Alasha Dec 30, 2016 12:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job pop star, I see head and shoulders here but despite, 2017 pick
Nov 01, 2016 9:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I like what I see
Nov 01, 2016 9:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
That's right!:)
Pop Star
Pop Star Aug 19, 2016 5:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Headed to 86 in two weeks
Jeffrey Wright
Jeffrey Wright Apr 16, 2016 8:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Even after having to pay merk 200m?
David Simpson
David Simpson Feb 29, 2016 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What a bargain at these levels.....buy buy buy.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email